2009
DOI: 10.1007/s10875-009-9275-y
|View full text |Cite
|
Sign up to set email alerts
|

CD8+ Cell Anti-HIV Activity Rapidly Increases Upon Discontinuation of Early Antiretroviral Therapy

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
9
0

Year Published

2011
2011
2019
2019

Publication Types

Select...
7

Relationship

2
5

Authors

Journals

citations
Cited by 11 publications
(9 citation statements)
references
References 47 publications
0
9
0
Order By: Relevance
“…The finding of decreased frequencies of CD45RA Ϫ CD27 ϩ CD8 ϩ cells in patients receiving antiretroviral therapy ( Fig. 1A and B) provides an explanation for the previously observed loss of CNAR activity in CD8 ϩ cells from these subjects (22,44). Still, differences in CD8 ϩ cell subset frequencies, as measured by flow cytometry, do not necessarily account for a loss or gain of antiviral function.…”
Section: Discussionmentioning
confidence: 66%
See 2 more Smart Citations
“…The finding of decreased frequencies of CD45RA Ϫ CD27 ϩ CD8 ϩ cells in patients receiving antiretroviral therapy ( Fig. 1A and B) provides an explanation for the previously observed loss of CNAR activity in CD8 ϩ cells from these subjects (22,44). Still, differences in CD8 ϩ cell subset frequencies, as measured by flow cytometry, do not necessarily account for a loss or gain of antiviral function.…”
Section: Discussionmentioning
confidence: 66%
“…This CD8 ϩ cell noncytotoxic antiviral response (CNAR) becomes evident during the acute stage of infection (22,38), varies in magnitude among HIV-infected persons (21,35,52), and directly correlates with a healthy clinical state (3,6,7,14,25,35). Strong CNAR activity is a feature of long-term survivors (LTS) of HIV infection (3,14).…”
Section: Cd8mentioning
confidence: 99%
See 1 more Smart Citation
“…While evidence has indicated increased CD4 ϩ T cell counts after HAART, it has also been reported that noncytotoxic CD8 ϩ T cell anti-HIV responses may contribute significantly to immune system reconstitution by suppressing HIV replication (54). Clinical studies have demonstrated the use of the CD4/CD8 ratio as an indicator of immunocompromise in HIV-infected individuals, with high sensitivity (98%) and specificity (Ͼ98%), particularly for children Ͻ2 years of age (55,56).…”
Section: Discussionmentioning
confidence: 99%
“…Despite the potential to combine viral vectors, most recently published Phase I trials of new candidate HIV vaccines employ a DNA prime, adenoviral boost regime that induces only modest T cell frequencies (median IFN-g spot forming cells per million of 891 [32] and 237 [33]) or employ only a single vector [34]. The addition of a second viral vector such as a poxvirus, which is currently the best boosting vector, should further enhance T cell immunity, particularly the CD8 + T cell frequencies that are so important to HIV immunity [35]. Table 1 illustrates how the specific properties of each of the main groups of viral vectors are employed to harness their respective advantages.…”
Section: The Long-awaited Success Of Viral-vectored Vaccines In Clinimentioning
confidence: 99%